Abstract |
Long-term feeding of a high-fat diet (HFD) induces endotoxemia and gastrointestinal inflammation by disturbing gut microbiota composition and membrane permeability, resulting in the acceleration of obesity. Some probiotics exhibit anti-inflammatory effects in vitro and in vivo. Therefore, we hypothesized that anti-inflammatory probiotics could lead to the simultaneous attenuation of endotoxemia, liver steatosis, obesity, and colitis in mice with HFD-induced obesity. Herein, we examined whether Lactobacillus plantarum LC27 and/or Bifidobacterium longum LC, which significantly suppressed NF-κB activation in lipopolysaccharide- or fecal lysate-stimulated Caco-2 cells, could simultaneously alleviate liver steatosis and colitis in mice with HFD-induced obesity. Oral administration of LC27, LC67, or their (3:1) mixture (LM) reduced HFD-induced aspartate transaminase, alanine transaminase, triglyceride, total cholesterol, and lipopolysaccharide levels in the blood and liver. Their treatments also suppressed HFD-induced NF-κB activation and increased AMP-activated protein kinase (AMPK) activation and claudin-1 and occludin expression in the liver and colon. Moreover, LC27, LC67, or LM treatment reduced HFD-induced Firmicutes and Proteobacteria populations in gut microbiota and fecal lipopolysaccharide production. The hypothesis was supported by the findings that anti-inflammatory LC27 and/or LC67 simultaneously alleviated liver steatosis, obesity, and colitis by regulating NF-κB and AMPK activation through the inhibition of gut microbiota lipopolysaccharide production.
|
Authors | Hye In Kim, Jeon-Kyung Kim, Jae-Young Kim, Se-Eun Jang, Myung Joo Han, Dong-Hyun Kim |
Journal | Nutrition research (New York, N.Y.)
(Nutr Res)
Vol. 67
Pg. 78-89
(07 2019)
ISSN: 1879-0739 [Electronic] United States |
PMID | 30982555
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2019 Elsevier Inc. All rights reserved. |
Topics |
- Animals
- Bifidobacterium longum
- Colitis
(drug therapy, etiology)
- Colon
(drug effects)
- Diet, High-Fat
(adverse effects)
- Disease Models, Animal
- Endotoxemia
(drug therapy, etiology)
- Fatty Liver
(drug therapy, etiology)
- Gastrointestinal Microbiome
(drug effects)
- Lactobacillus plantarum
- Male
- Mice
- Mice, Inbred C57BL
- Obesity
(drug therapy, etiology)
- Probiotics
(pharmacology)
|